Figure 2.
Trends in visceral adiposity (visceral to total adipose tissue [TAT] at the same level, A,B) and PLVI (C) and prevalence of different body compositions (BCs) defined by VAT or WBAT and PLVI after front-line treatment (D,E) and its impact in PFS and OS (F,G) in the PUC cohort. The * and ** indicate statistical significance among the groups (p < 0.001). ns stands for non-significant.